Increasing levels of pretreatment HIV drug resistance and safety concerns for dolutegravir use in women of reproductive age. (2019)

First Author: Inzaule SC
Attributed to:  Pathogen Genomics, Phenotype and Immunity (PGPI) & Basic Sciences Programme funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/qad.0000000000002277

PubMed Identifier: 31149946

Publication URI: http://europepmc.org/abstract/MED/31149946

Type: Journal Article/Review

Volume: 33

Parent Publication: AIDS (London, England)

Issue: 11

ISSN: 0269-9370